학술논문

IMPAACT P1066: raltegravir (RAL) safety and efficacy in HIV infected (+) youth two to 18 years of age through week 48
Document Type
Journal
Source
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY; OCT 2012, 15 p67-p68, 2p. Supplement: 3
Subject
Language
English
ISSN
17582652